Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.1260
-0.0229 (-15.40%)
Apr 3, 2025, 3:45 PM EST

Bioxytran Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Market Capitalization
132259442325
Upgrade
Market Cap Growth
-61.61%-63.00%33.18%89.57%-4.77%-43.42%
Upgrade
Enterprise Value
142360472525
Upgrade
Last Close Price
0.150.150.480.400.240.28
Upgrade
PB Ratio
-8.29-7.02-17.93-14.04-12.05-30.73
Upgrade
Debt / Equity Ratio
-0.86-0.62-0.66-0.67-0.83-1.06
Upgrade
Quick Ratio
0.030.010.080.020.020.22
Upgrade
Current Ratio
0.030.010.080.020.140.22
Upgrade
Return on Assets (ROA)
-996.21%-940.97%-545.10%-1181.99%-290.44%-796.50%
Upgrade
Return on Capital (ROIC)
------3793.40%
Upgrade
Earnings Yield
-20.57%-19.59%-4.17%-9.09%-10.61%-7.57%
Upgrade
Buyback Yield / Dilution
-19.23%-16.35%-8.57%-13.07%-9.78%-0.58%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.